Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
Clinical trial NCT00663260 · COMPLETED
Trial details
- NCT number
- NCT00663260
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-12-01
- Enrollment
- 631
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.